Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
A phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graft versus host disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL)
British Journal of Haematology, 09/15/09
Pulsipher MA et al. – Sirolimus-based GVHD prophylaxis can be given safely in this population and early survival results are promising. A phase III trial to test whether sirolimus decreases relapse and improves outcome after transplantation for ALL is ongoing.
Methods- Study cohort included 18 patients in high-risk (HR) first complete remission (CR1)
- 16 in HR CR2
- 17 in intermediate risk (IR) CR2
- 12 in CR3+
- 2-year event-free survival (EFS) of the cohort was 66%
- EFS of risk groups was 74%, 81%, 44% and 46% for CR1, IR CR2, HR CR2 and CR3+ patients
- Cumulative incidence of acute GVHD grade II–IV and III–IV was 38% and 21% respectively, while the cumulative incidence of chronic GVHD was 32%
- Cumulative incidence of transplant-related mortality and relapse was 10% and 25% respectively
- Cumulative incidence of chronic GVHD was 32%
- Significant toxicities included veno-occlusive disease (seven patients)
- Transplant-associated microangiopathy (three patients)
- Idiopathic pneumonitis (one patient)
Related Articles
A Phase I Study of the Mammalian Target of Rapamycin Inhibitor Sirolimus and MEC Chemotherapy in Relapsed and Refractory Acute Myelogenous Leukemia
Clinical Cancer Research, 10/26/09
Relevance Score: 88%
Current Approaches to the Use of Sirolimus In Renal Transplantation
Transplantation Proceedings, 11/05/09
Relevance Score: 87%
Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma
The Journal of Thoracic and Cardiovascular Surgery, 10/27/09
Relevance Score: 87%
Multiple coronary artery aneurysm formation one year and four years after sirolimus-eluting coronary stent implantation
Cardiovascular Revascularization Medicine, 10/16/09
Relevance Score: 84%
Resolution of late sirolimus-eluting stent thrombosis after tirofiban treatment
Heart and Vessels, 10/07/09
Relevance Score: 84%
Today in BMT/SCT...keeping you current
Receive free subspecialty "5-minute updates" via email
Nonmyeloablative and Reduced-Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation: A Clinical Review
American Journal of Clinical Oncology, 12/07/09
Performing allogeneic and autologous hematopoietic SCT in the outpatient setting: effects on infectious complications and early transplant outcomes
Bone Marrow Transplantation, 12/03/09
Dermatologic manifestations of hematopoietic stem cell transplantation: understanding and management
Expert Review of Dermatology, 12/03/09
Today in Leukemia/Lymphoma...keeping you current
Receive free subspecialty "5-minute updates" via email
Impact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myeloma
British Journal of Haematology, 12/08/09
Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia
Blood, 12/08/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Definitive chemoradiation therapy with capecitabine in locally advanced pancreatic cancer
Anti-Cancer Drugs, 12/08/09
Is gemcitabine an option in BCG-refractory nonmuscle-invasive bladder cancer? A single-arm prospective trial
Anti-Cancer Drugs, 12/08/09
Impact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myeloma
British Journal of Haematology, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


